Sensorion to Attend the American Society of Gene & Cell Therapy (ASGCT) and Gene Therapy Analytical Development Conferences in May 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Associated Vector Discovery Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
(0) Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces the participation of members of the company's senior management team in three R&D and investor conferences being held virtually during May 2021. Sensorion's Head of CMC Gene Therapy Christine le Bec will co-chair a scientific session on the " Development of AAV Capsid Variants" at the American Society of Gene Cell Therapy (ASGCT) Annual meeting, ta...